Pinto Joshua

PresidentNeumora Therapeutics, Inc. (NMRA) · full profile →Form 4 · filed May 30, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
14
0 non-derivative · 14 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 28, 2025Disposed to issuer(D)127K0
May 28, 2025Disposed to issuer(D)170K0
May 28, 2025Disposed to issuer(D)3.0M0
May 28, 2025Grant(A)223K223K
May 28, 2025Grant(A)271K271K
May 28, 2025Grant(A)223K223K
May 28, 2025Grant(A)720K720K
May 28, 2025Grant(A)127K127K
May 28, 2025Grant(A)170K170K
May 28, 2025Grant(A)3.0M3.0M
May 28, 2025Disposed to issuer(D)223K0
May 28, 2025Disposed to issuer(D)271K0
May 28, 2025Disposed to issuer(D)223K0
May 28, 2025Disposed to issuer(D)720K0

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-079908) within minutes of acceptance. Every field above traces to the original document. Verify it directly: